Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 407026, 9 pages
http://dx.doi.org/10.1155/2014/407026
Clinical Study

Hypofractionated High-Dose Irradiation with Positron Emission Tomography Data for the Treatment of Glioblastoma Multiforme

1Chubu Medical Center for Prolonged Traumatic Brain Dysfunction, Kizawa Memorial Hospital, Minokamo, Gifu 505-0034, Japan
2Department of Neurosurgery, Chubu Medical Center for Prolonged Traumatic Brain Dysfunction, 630 Shimokobi, Kobi-cho, Minokamo, Gifu 505-0034, Japan
3Department of Radiation Oncology, Kizawa Memorial Hospital, Minokamo, Gifu 505-0034, Japan
4Department of Neurosurgery, Kizawa Memorial Hospital, Minokamo, Gifu 505-0034, Japan
5Department of Neurosurgery, Gifu University Graduate School of Medicine, Gifu 501-1193, Japan

Received 11 February 2014; Accepted 4 May 2014; Published 22 May 2014

Academic Editor: Yi-Xiang Wang

Copyright © 2014 Kazuhiro Miwa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. D. Walker, S. B. Green, D. P. Byar et al., “Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery,” The New England Journal of Medicine, vol. 303, no. 23, pp. 1323–1329, 1980. View at Google Scholar
  2. P. L. Jager, W. Vaalburg, J. Pruim, E. G. E. De Vries, K.-J. Langen, and D. A. Piers, “Radiolabeled amino acids: basic aspects and clinical applications in oncology,” Journal of Nuclear Medicine, vol. 42, no. 3, pp. 432–445, 2001. View at Google Scholar · View at Scopus
  3. W. J. Curran Jr., C. B. Scott, J. Horton et al., “Recursive partitioning analysis of prognostic factors in three radiation therapy oncology group malignant glioma trials,” Journal of the National Cancer Institute, vol. 85, no. 9, pp. 704–710, 1993. View at Google Scholar · View at Scopus
  4. L. W. Kracht, H. Miletic, S. Busch et al., “Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology,” Clinical Cancer Research, vol. 10, no. 21, pp. 7163–7170, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Mahasittiwat, J. Mizoe, A. Hasegawa et al., “l-[METHYL-11C] methionine positron emission tomography for target delineation in malignant gliomas: impact on results of carbon ion radiotherapy,” International Journal of Radiation Oncology Biology Physics, vol. 70, no. 2, pp. 515–522, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Stupp, W. P. Mason, M. J. Van Den Bent et al., “Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma,” New England Journal of Medicine, vol. 352, no. 10, pp. 987–996, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Iuchi, K. Hatano, Y. Narita, T. Kodama, T. Yamaki, and K. Osato, “Hypofractionated high-dose irradiation for the treatment of malignant astrocytomas using simultaneous integrated boost technique by IMRT,” International Journal of Radiation Oncology Biology Physics, vol. 64, no. 5, pp. 1317–1324, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Sultanem, H. Patrocinio, C. Lambert et al., “The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trial,” International Journal of Radiation Oncology Biology Physics, vol. 58, no. 1, pp. 247–252, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. N. S. Floyd, S. Y. Woo, B. S. Teh et al., “Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme,” International Journal of Radiation Oncology Biology Physics, vol. 58, no. 3, pp. 721–726, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. V. Panet-Raymond, L. Souhami, D. Roberge et al., “Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: a safety and efficacy analysis,” International Journal of Radiation Oncology Biology Physics, vol. 73, no. 2, pp. 473–478, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Nakamatsu, M. Suzuki, Y. Nishimura et al., “Treatment outcomes and dose-volume histogram analysis of simultaneous integrated boost method for malignant gliomas using intensity-modulated radiotherapy,” International Journal of Clinical Oncology, vol. 13, no. 1, pp. 48–53, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Pirotte, S. Goldman, O. Dewitte et al., “Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures,” Journal of Neurosurgery, vol. 104, no. 2, pp. 238–253, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Aki, N. Nakayama, S. Yonezawa et al., “Evaluation of brain tumors using dynamic (11)C-methionine-PET,” Journal of Neuro-Oncology, vol. 109, no. 1, pp. 115–122, 2012. View at Publisher · View at Google Scholar
  14. A. Grosu, W. A. Weber, E. Riedel et al., “L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy,” International Journal of Radiation Oncology Biology Physics, vol. 63, no. 1, pp. 64–74, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Miwa, J. Shinoda, H. Yano et al., “Discrepancy between lesion distributions on methionine PET and MR images in patients with glioblastoma multiforme: insight from a PET and MR fusion image study,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 75, no. 10, pp. 1457–1462, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Matsuo, K. Miwa, O. Tanaka et al., “Impact of [11C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning,” International Journal of Radiation Oncology Biology Physics, vol. 82, no. 1, pp. 83–89, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. I. H. Lee, M. Piert, D. Gomez-Hassan et al., “Association of 11C-Methionine PET uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiforme,” International Journal of Radiation Oncology Biology Physics, vol. 73, no. 2, pp. 479–485, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Miwa, M. Matsuo, J. Shinoda et al., “Simultaneous integrated boost technique by helical tomotherapy for the treatment of glioblastoma multiforme with 11C-methionine PET: report of three cases,” Journal of Neuro-Oncology, vol. 87, no. 3, pp. 333–339, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Gonzalez, A. J. Kumar, C. A. Conrad, and V. A. Levin, “Effect of bevacizumab on radiation necrosis of the brain,” International Journal of Radiation Oncology Biology Physics, vol. 67, no. 2, pp. 323–326, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. V. A. Levin, L. Bidaut, P. Hou et al., “Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system,” International Journal of Radiation Oncology Biology Physics, vol. 79, no. 5, pp. 1487–1495, 2011. View at Publisher · View at Google Scholar · View at Scopus